Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NBank is the development and promotional bank of the German state of Lower Saxony (Niedersachsen), not a biotech, pharma, or healthcare operating company. It provides public financing, grants, loans, guarantees, and investment support for businesses, municipalities, institutions, and individuals across areas such as economic development, housing, infrastructure, labor, and innovation. Through its investment arm, NBank Capital, it also makes venture and growth investments in startups and SMEs, including occasional investments in life sciences-related companies. For biotech analyst purposes, NBank is best understood as a regional public-sector financing institution and investor rather than a drug developer, healthcare services provider, or life sciences platform company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NBank.